Pear Therapeutics, Inc.

PEAR · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Operating Activities
Net Income-$26-$31$5-$24
Dep. & Amort.$2$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$4$3$3
Change in WC-$3-$1-$1-$5
Other Non-Cash-$1$3-$39-$12
Operating Cash Flow-$24-$23-$30-$37
Investing Activities
PP&E Inv.-$1-$1-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$23-$43-$23-$43
Inv. Sales/Matur.$13$23$24$0
Other Inv. Act.$23$43$0$0
Investing Cash Flow$12$22-$0-$44
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$1$0
Financing Cash Flow$1$0$1$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$11-$0-$29-$80
Supplemental Information
Beg. Cash$60$61$90$170
End Cash$49$60$61$90
Free Cash Flow-$25-$24-$31-$37